1. Brakedal B, et al. The NADPARK study: A randomized phase I trial of nicotinamide riboside supplementation in Parkinson's disease. Cell Metab. 2022 Mar 1;34(3):396-407.e6. doi: 10.1016/j.cmet.2022.02.001. PMID: 35235774.
2. Chellappa K, et al. NAD precursors cycle between host tissues and the gut microbiome. Cell Metab. 2022 Dec 6;34(12):1947-1959.e5. doi: 10.1016/j.cmet.2022.11.004. PMID: 36476934; PMCID: PMC9825113.
3. Elhassan YS, et al. Nicotinamide Riboside Augments the Aged Human Skeletal Muscle NAD+ Metabolome and Induces Transcriptomic and Anti- inflammatory Signatures. Cell Rep. 2019 Aug 13;28(7):1717-1728.e6. doi: 10.1016/j.celrep.2019.07.043. PMID: 31412242; PMCID: PMC6702140.
4. Giacalone S, Spigariolo CB, Bortoluzzi P, Nazzaro G. Oral nicotinamide: The role in skin cancer chemoprevention. Dermatol Ther. 2021 May;34(3):e14892. doi: 10.1111/dth.14892. Epub 2021 Mar 1. PMID: 33595161.
5. Chen AC, et al. A Phase 3 Randomized Trial of Nicotinamide for Skin-Cancer Chemoprevention. N Engl J Med. 2015 Oct 22;373(17):1618-26. doi: 10.1056/NEJMoa1506197. PMID: 26488693.
6. Pirinen E, et al. Niacin cures systemic NAD+ deficiency and improves muscle performance in adult-onset mitochondrial myopathy. Cell Metab. 2020; 31:1078-1090.
7. University of New South Wales. “Scientists unveil a giant leap for anti-aging.” Science Daily. March 23, 2017.
8. Elysium Health. “5 reasons scientists are studying NAD+, the “Golden Nucleotide.” Endpoints. May 22, 2017.
9. Elysium. Scientific Advisory Board. Accelerating the pace of discovery. [https://www.elysiumhealth.com/en-us/science/scientific-advisory-board]
10. Freeberg, KA, et al. Dietary supplementation with NAD+-boosting compounds in humans: Current knowledge and future directions. Jrnl Geron: Med Sci, 17 April 2023;1-14
11. Das A, et al. “Impairment of an endothelial NAD+ -H2S signaling network is a reversible cause of vascular aging.” Cell. 2018:173;74-89.
12. Das A, et al. “Impairment of an endothelial NAD+ -H2S signaling network is a reversible cause of vascular aging.” Cell. 2018:173;74-89.
13. Wiley C and Campisi J. “NAD+ controls neural stem cell fate in the aging brain.” EMBO J. 2014;33(12):1289-1291.
14. Igarashi M, et al. “NAD+ supplementation rejuvenates aged gut adult stem cells.” Aging Cell. 2019;18(3):e12935.
15. University of New South Wales. “Scientists unveil a giant leap for anti-aging.” Science Daily. March 23, 2017. Study: Li J, et al. “A conserved NAD binding pocket that regulates protein-protein interactions during aging.” Science. 2017;355(6331):1312-1317.
16. Chellappa K, et al. NAD precursors cycle between host tissues and the gut microbiome. Cell Metab. 2022 Dec 6;34(12):1947-1959.e5. doi: 10.1016/j.cmet.2022.11.004. PMID: 36476934; PMCID: PMC9825113.
17. Brakedal B, et al. The NADPARK study: A randomized phase I trial of nicotinamide riboside supplementation in Parkinson's disease. Cell Metab. 2022 Mar 1;34(3):396-407.e6. doi: 10.1016/j.cmet.2022.02.001. PMID: 35235774.
18. Elhassan YS, et al. Nicotinamide Riboside Augments the Aged Human Skeletal Muscle NAD+ Metabolome and Induces Transcriptomic and Anti- inflammatory Signatures. Cell Rep. 2019 Aug 13;28(7):1717-1728.e6. doi: 10.1016/j.celrep.2019.07.043. PMID: 31412242; PMCID: PMC6702140.
19. Giacalone S, Spigariolo CB, Bortoluzzi P, Nazzaro G. Oral nicotinamide: The role in skin cancer chemoprevention. Dermatol Ther. 2021 May;34(3):e14892. doi: 10.1111/dth.14892. Epub 2021 Mar 1. PMID: 33595161.
20. Chen AC, et al. A Phase 3 Randomized Trial of Nicotinamide for Skin-Cancer Chemoprevention. N Engl J Med. 2015 Oct 22;373(17):1618-26. doi: 10.1056/NEJMoa1506197. PMID: 26488693.
21. NIH Research Matters. “Researchers find clue to repair of aging DNA.” National Institutes of Health. April 4, 2017. Study: Li J, et al. “A conserved NAD binding pocket that regulates protein-protein interactions during aging.” Science. 2017;355(6331):1312-1317.
https://newsroom.unsw.edu.au/news/health/unsw-harvard-scientists-unveil-giant-leap-anti-ageing
22. Li J, et al. “A conserved NAD binding pocket that regulates protein-protein interactions during aging.” Science. 2017;355(6331):1312-1317.
23. Hou Y, et al. “NAD+ supplementation normalizes key Alzheimer’s features and DNA damage responses in a new AD mouse model with introduced DNA repair deficiency.” Proc Natl Acad Sci U S A. 2018;115(8):E1876-E1885.
24. Schöndorf DC, et al. “The NAD+ precursor nicotinamide riboside rescues mitochondrial defects and neuronal loss in iPSC and fly models of Parkinson’s disease.” Cell Rep. 2018;23(10):2976-2988.
25. Zhou M, et al. “Neuronal death induced by misfolded prion protein is due to NAD+ depletion and can be relieved in vitro and in vivo by NAD+ replenishment.” Brain. 2015;138(Pt 4):992-1008.
26. Stein LR and Imai S. “Specific ablation of Nampt in adult neural stem cells recapitulates their functional defects during aging.” EMBO J. 2014;33(12):1321-1340.
27. Martens CR, et al. “Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults.” Nat Commun. 2018;9(1):1286.
28. Reyes LA, et al. “Depletion of NADP(H) due to CD38 activation triggers endothelial dysfunction in the postischemic heart.” Proc Natl Acad Sci U S A. 2015;112(37):11648-11653.
29. Brown KD, et al. “Activation of SIRT3 by the NAD= precursor nicotinamide riboside protects from noise-induced hearing loss.” Cell Metab. 2014;20(6):1059-1068.
30. Das A, et al. “Impairment of an endothelial NAD+ -H2S signaling network is a reversible cause of vascular aging.” Cell. 2018;173(1):74-89.
31. Fu X, et al. “Repletion of nicotinamide adenine dinucleotide restores adult stem cell function and extends lifespan in mice.” AME Med J. 2017;2:96.
32. Poyan Mehr A, et al. “De novo NAD+ biosynthetic impairment in acute kidney injury in humans.” Nat Med. 2018;24(9):1351-1359.
33. Igarashi M, et al. “NAD+ supplementation rejuvenates aged gut adult stem cells.” Aging Cell. 2019;18(3):e12935.
34. Tullius SG, et al. “NAD+ protects against EAE by regulating CD4+ T-cell differentiation.” Nat Commun. 2014;5:5101.
35. Yoshino J, et al. “Nicotinamide mononucleotide, a key NAD(+) intermediate, treats the pathophysiology of diet- and age-induced diabetes in mice.” Cell Metab. 2011;14(4):528-536.
36. Peek CB, et al. “Circadian clock NAD+ cycle drives mitochondrial oxidative metabolism in mice.” Science. 2013;342(6158).
37. Imai Si, Guarente L NAD+ and sirtuins in aging and disease. Trends Cell Biol. 2014 Aug;24(8):464-71.
doi: 10.1016/j.tcb.2014.04.002. Epub 2014 Apr 29.
38. Pirinen E, et al. Niacin cures systemic NAD+ deficiency and improves muscle performance in adult-onset mitochondrial myopathy. Cell Metab. 2020; 31:1078-1090.
39. Otsuki L and Brand AH. “Cell cycle heterogeneity directs the timing of neural stem cell activation from quiescence.” Science. 2018;360(6384):99-102.
40. Urba´ n, N., Blomfield, I. M., & Guillemot, F. (2019). Quiescence of Adult Mammalian Neural Stem Cells: A Highly Regulated Rest. Neuron, 104(5), 834-848.
41. Zhang, H., Ryu, D., Wu, Y., Gariani, K., Wang, X., Luan, P., ... & Cantó, C. (2016). NAD+ repletion improves mitochondrial and stem cell function and enhances life span in mice. Science, 352(6292), 1436-1443.
Pilz, G. A., Bottes, S., Betizeau, M., Jörg, D. J., Carta, S., Simons, B. D., & Helmchen, F. (2018). Live imaging of neurogenesis in the adult mouse hippocampus. Science, 359(6376), 658-662
42. Marsa L. “Neural stem cells may repair damage from aging and injuries.” Discover. January 3, 2019.
43. Zhang Y, et al. “Hypothalamic stem cells control aging speed partly through exosomal miRNAs.” Nature. 2017;548(7665):52-57.
44. Blanding M, et al. “Feed your stem cells.” Tufts Now. October 19, 2015.
45. Zhao Y, et al. “Regenerative neurogenesis after ischemic stroke promoted by nicotinamide phosphoribosyltransferase-nicotinamide adenine dinucleotide cascade.” Stroke. 2015;46(7):1966-1974.
46. Hou Y, et al. “NAD+ supplementation normalizes key Alzheimer’s features and DNA damage responses in a new AD mouse model with introduced DNA repair deficiency.” Proc Natl Acad Sci U S A. 2018;115(8):E1876-E1885.
47. Zhang H, et al. “NAD+ repletion improves mitochondrial and stem cell function and enhances life span in mice.” Science. 2016;352(6292):1436-1443.
48. Kwon D. “Biologists discover unknown powers in mighty mitochondria.” Quanta Magazine. March 18, 2019.
49. Ming G and Song H. “Adult Neurogenesis in the Mammalian Brain: Significant Answers and Significant Questions” Neuron. 2011 May 26; 70(4): 687-702.
50. Gomes AP, et al. “Declining NAD+ induces a pseudohypoxic state disrupting nuclear-mitochondrial communication during aging.” Cell. 2013;155(7):1624-1638.
51. Wei W, et al. “Germline selection shapes human mitochondrial DNA diversity.” Science. 2019;364(6442).
52. Camacho-Pereira J, et al. “CD38 dictates age-related NAD decline and mitochondrial dysfunction through an SIRT3-dependent mechanism.” Cell Metab. 2016;23(6):1127-1139.
53. Boslett J, et al. Luteolinidin protects the postischemic heart through CD38 inhibition with preservation of NAD(P)(H). J Pharmacol Exp Ther 361:99–108, April 2017